Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0149514 (bronchitis)
 6,902 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

16 silicone stents and 9 expandable metallic stents (Strecker-stents) were implanted in 22 patients (16 x tumors of central bronchial tree, 6 x stenosis of benign conditions). The silicone stents were mainly implanted in the trachea and main bronchi, the metallic stents in lobar bronchi. In all cases we succeeded in implantation without complications. With both stent models an immediate relief of dyspnea and respiratory failure was achieved in all cases. The average period of follow-up is 65 days, the longest 105 days (silicone stents) respectively 306 days (metallic stents). All stents were tolerated well besides one with a feeling of intrathoracic pressure. Complications were dislocation (1 x), occlusive tumor growth (1 x), granulations (1 x), suppurative bronchitis (2 x), growth of tissue through the wall of metallic stents (1 x) and restenosis by indurated secretions (2 x). Though the long term results were well with different types of stents, which are available today, the expandable stent woven of metallic wire, seems to fit best to clinical needs.
 ...
PMID:[Tracheobronchial stents--indications and possibilities]. 176 54

Bronchofibroscopy was performed in 4736 patients in the Moscow Endoscopic Center (S. P. Botkin Hospital) over the period of September 1984-December 1987. Central lung cancer was diagnosed in 139, of them peribronchial tumor growth was determined in 15. Deforming bronchitis was diagnosed in 283 patients, 23 of them were admitted to hospital with the diagnosis of central lung cancer. Differential diagnosis of peribronchial central lung cancer and deforming bronchitis is based on findings of a combined study including roentgenography, tomography, bronchofibroscopy with biopsy for subsequent cytological and histological investigation.
 ...
PMID:[Differential diagnosis of deforming bronchitis and the peribronchial form of central lung cancer]. 227 Jun 58

Six breeding groups of chickens, each characterized by a different haplotype of the B blood group system, were challenged with different classes of antigens, namely Newcastle disease vaccine (ND), infectious bronchitis vaccine (IB), infectious bursal disease viral agent (IBD), Salmonella pullorum antigen (P), and sheep red blood cells (SRBC). Parents were challenged at 20 weeks of age, and their offspring were challenged at 3 weeks of age. Blood samples were taken from the parents at 1 week after challenge, and from the offspring at 1, 2, 3, and 4 weeks after challenge for determination of antibody titers to each antigen. The offspring were also challenged at 8 weeks of age in the wing-web with Rous sarcoma virus (RSV). Tumor scores were taken weekly on individual chickens for the next 10 weeks. There were significant differences (P less than .01) between breeding groups of parents for antibody titer responses to ND, IB, P, and SRBC. There were significant differences (P less than .05) between the breeding groups of offspring for antibody titer responses to ND, IB, IBD, P, and SRBC. There were significant (P less than .01) differences between the breeding groups in the accumulative tumor scores over the 10-week period. The lines that cause regression of Rous sarcomas (R-lines) were significantly (P less than .01) superior in resisting tumor growth to those lines that allow progressive growth of tumors (Pr-lines). The only antigen to which the R-lines gave significantly (P less than .01) higher titers of antibody responses than the Pr-lines was SRBC.
 ...
PMID:Genetic aspects of antibody responses in chickens to different classes of antigens. 370 75